Abstract
Type 2 diabetes is characterized by β and α cell dysfunction. We used phasor-FLIM (Fluorescence Lifetime Imaging Microscopy) to monitor oxidative phosphorylation and glycolysis in living islet cells before and after glucose stimulation. In healthy cells, glucose enhanced oxidative phosphorylation in β cells and suppressed oxidative phosphorylation in α cells. In Type 2 diabetes, glucose increased glycolysis in β cells, and only partially suppressed oxidative phosphorylation in α cells. FLIM uncovers key perturbations in glucose induced metabolism in living islet cells and provides a sensitive tool for drug discovery in diabetes.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Diabetes Mellitus, Experimental / drug therapy
-
Diabetes Mellitus, Experimental / metabolism*
-
Diabetes Mellitus, Experimental / pathology
-
Diabetes Mellitus, Type 2 / drug therapy
-
Diabetes Mellitus, Type 2 / metabolism*
-
Diabetes Mellitus, Type 2 / pathology
-
Glucagon-Secreting Cells / drug effects
-
Glucagon-Secreting Cells / metabolism*
-
Glucose / pharmacology*
-
Glycolysis
-
Humans
-
Insulin-Secreting Cells / drug effects
-
Insulin-Secreting Cells / metabolism*
-
Islet Amyloid Polypeptide / metabolism
-
Male
-
Mice
-
Microscopy, Fluorescence
-
Molecular Imaging / methods*
-
Oxidative Phosphorylation
-
Rats
-
Rats, Sprague-Dawley
-
Rats, Transgenic
Substances
-
Islet Amyloid Polypeptide
-
Glucose